Literature DB >> 26492903

Adequacy of diagnostic tests and surgical management of symptomatic invasive lobular carcinoma of the breast.

D J Hadjiminas1, K E Zacharioudakis1, M K Tasoulis1, J C C Hu1, S Lanitis1, R Bright-Thomas1, N G Dimopoulos1, G Hornzee1, D A Cunningham1, S J Cleator1, R Al Mufti1.   

Abstract

INTRODUCTION: Invasive lobular carcinoma (ILC) presents diagnostic and therapeutic challenges as it produces subtle radiological changes. It has been suggested that it is not suitable for breast conserving surgery (BCS). The aim of this study was to ascertain the diagnostic adequacy of modern mammography and ultrasonography in the context of a fast track symptomatic diagnostic clinic in the UK. It also sought to compare the mastectomy, re-excision and BCS rates for ILC with those for invasive ductal carcinoma (IDC).
METHODS: A retrospective analysis of prospectively collected data was carried out on all new symptomatic cancers presenting to the one-stop diagnostic clinic of a single breast unit between 1998 and 2007.
RESULTS: Compared with IDC, ILC was significantly larger at presentation (46mm vs 25mm), needed re-excision after BCS more often (38.8% vs 22.3%) and required mastectomy more frequently (58.8% vs 40.8%). Although mammography performs poorly in diagnosing ILC compared with IDC, when combined with ultrasonography, sensitivity of the combined imaging was not significantly different between these two histological types.
CONCLUSIONS: Provided ultrasonography is performed, standard radiological imaging is adequate for initial diagnosis of symptomatically presenting ILC but some additional preoperative workup should clearly be employed to reduce the higher number of reoperations for this histological type.

Entities:  

Keywords:  Breast conserving surgery; Breast ultrasonography; Invasive ductal carcinoma; Invasive lobular carcinoma; Mammography

Mesh:

Year:  2015        PMID: 26492903      PMCID: PMC5096609          DOI: 10.1308/rcsann.2015.0034

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  14 in total

1.  Invasive lobular and ductal carcinoma: mammographic findings and stage at diagnosis.

Authors:  G M Newstead; P B Baute; H K Toth
Journal:  Radiology       Date:  1992-09       Impact factor: 11.105

2.  The role of MRI in invasive lobular carcinoma.

Authors:  Carla Boetes; Jeroen Veltman; Lya van Die; Peter Bult; Theo Wobbes; Jelle O Barentsz
Journal:  Breast Cancer Res Treat       Date:  2004-07       Impact factor: 4.872

3.  Invasive lobular carcinoma: sonographic features of cancers detected in a BreastScreen Program.

Authors:  J N Cawson; E M Law; A M Kavanagh
Journal:  Australas Radiol       Date:  2001-02

4.  The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast.

Authors:  R M Mann; J Veltman; J O Barentsz; T Wobbes; J G Blickman; C Boetes
Journal:  Eur J Surg Oncol       Date:  2007-06-15       Impact factor: 4.424

5.  Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients.

Authors:  K N Krecke; J J Gisvold
Journal:  AJR Am J Roentgenol       Date:  1993-11       Impact factor: 3.959

6.  Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.

Authors:  Emad A Rakha; Maysa E El-Sayed; Desmond G Powe; Andrew R Green; Hany Habashy; Matthew J Grainge; John F R Robertson; Roger Blamey; Julia Gee; Robert I Nicholson; Andrew H S Lee; Ian O Ellis
Journal:  Eur J Cancer       Date:  2007-11-26       Impact factor: 9.162

7.  The effect of multiple reexcisions on the risk of local recurrence after breast conserving surgery.

Authors:  M J O'Sullivan; T Li; G Freedman; M Morrow
Journal:  Ann Surg Oncol       Date:  2007-07-26       Impact factor: 5.344

8.  Trends in incidence rates of invasive lobular and ductal breast carcinoma.

Authors:  Christopher I Li; Benjamin O Anderson; Janet R Daling; Roger E Moe
Journal:  JAMA       Date:  2003-03-19       Impact factor: 56.272

9.  Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns.

Authors:  X Sastre-Garau; M Jouve; B Asselain; A Vincent-Salomon; P Beuzeboc; T Dorval; J C Durand; A Fourquet; P Pouillart
Journal:  Cancer       Date:  1996-01-01       Impact factor: 6.860

10.  Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis.

Authors:  E J Cornford; A R Wilson; E Athanassiou; M Galea; I O Ellis; C W Elston; R W Blamey
Journal:  Br J Radiol       Date:  1995-05       Impact factor: 3.039

View more
  1 in total

1.  Response of metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly mediated by the adaptive immune system.

Authors:  Sjoerd Klarenbeek; Chris W Doornebal; Sjors M Kas; Nicola Bonzanni; Jinhyuk Bhin; Tanya M Braumuller; Ingrid van der Heijden; Mark Opdam; Philip C Schouten; Kelly Kersten; Roebi de Bruijn; Daniel Zingg; Julia Yemelyanenko; Lodewyk F A Wessels; Karin E de Visser; Jos Jonkers
Journal:  Oncoimmunology       Date:  2020-02-12       Impact factor: 8.110

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.